Sub-Micrometer Particle Production by Pressurized Metered Dose Inhalers

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 17, Issue 1, 2004, Pages 33-42

  Crampton, Mark ^a   Kinnersley, Rob ^a   Ayres, Jon ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; FLUTICASONE PROPIONATE; IPRATROPIUM BROMIDE; SALBUTAMOL; SALMETEROL XINAFOATE;

AEROSOL; ARTICLE; DEVICE; DOSIMETER; DRUG FORMULATION; DRUG SCREENING; ENERGY YIELD; INHALER; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPE; STATISTICAL SIGNIFICANCE; TECHNIQUE; ULTRASTRUCTURE;

AEROSOL PROPELLANTS; AEROSOLS; BECLOMETHASONE; CHLOROFLUOROCARBONS; GLUCOCORTICOIDS; HYDROCARBONS, FLUORINATED; METERED DOSE INHALERS; PARTICLE SIZE;

EID: 1942437003     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/089426804322994442     Document Type: Article

References (25)

1. Donaldson, K., Li, X.Y., and MacNee, W. 1998. Ultrafine (nanometre) particle mediated lung injury. J. Aerosol. Sci. 29:553-560.
2. Donaldson, K., Stone, V., Clouter, A., et al. 2001. Ultrafine particles. Occup. Environ. Med. 58:211-216.
3. Howard, C.V., Donaldson, K., Williams, M., et al. 2000. Ultrafine particles: mechanisms of lung injury. Philos. Trans. R. Soc. Lond. Ser. A - Math. Phys. Eng. Sci. 358:2748-2749.
4. Ferin, J., Oberdorster, G., and Penney, D. P. 1992. Pulmonary retention of ultrafine and fine particles in rats. Am. J. Respir. Cell. Mol. Biol. 6:535-542.
5. Seaton, A., Soutar, A., Crawford, V., et al. 1999. Particulate air pollution and the blood. Thorax 54:1027-1032.
6. Montreal Protocol. 1994. The Montreal Protocol on substances that deplete the ozone layer. Final Act (Nairobi:UNEP,1987). Fed Reg. 59.
7. Davies, R. 1998. Improvements in delivery with an extra fine beclomethasone aerosol Int. J. Clin. Pract. 28-32.
8. Hiller, C., Mazumder, M., Wilson, D., et al. 1978. Aerodynamic size distribution of metered-does Brochodilator aerosols. Am. J. Respir. Crit. Care Med. 311-317.
9. Nagel, M.W., Wiersema, K.J., Bates, S.L., et al. 2002. Size analysis of a pressurized metered dose inhaler-delivered solution formulation by an Aerosizer-LD time-of-flight aerosol particle size spectrometer. J. Aerosol Med. 15:75-85.
10. Mitchell, J.P., and Nagel, M.W. 1996. An assessment of the API Aerosizer® for the real-time measurement of medical aerosols from pressurized metered-dose inhaler (pMDI) systems. Aerosol Sci. Technol. 25:411-423.
11. Mitchell, J.P., Nagel, M.W., and Cheng, Y.S. 1999. Use of the Aerosizer® aerodynamic particle size analyzer to characterize aerosols from pressurized metered-dose inhalers (pMDIs) for medication delivery. J. Aerosol. Sci. 30:467-477.
12. Vecellio None, L., Grimbert, D., Becquemin, M.H., et al. 2001. Validation of laser diffraction method as a substitute for cascade impaction in the European Project for a Nebulizer Standard. J. Aerosol Med. 14:107-114.
13. Marjamaki, M., Keskinen, J., Chen, D.R., et al. 2000. Performance evaluation of the electrical low-pressure impactor (ELPI). J. Aerosol. Sci. 31:249-261.
14. Knutson, E.O., and Whiltby, K. T. 1975. Aerosol classification by electric mobility: apparatus, theory, and applications. J. Aerosol Sci. 6:443-451.
15. U.S. Pharmacopeia. 1992. Aerosol (601). Seventh Supplement. 22nd rev.
16. Stein, S.W., Beck, T.J., and Gabario, B.J. 2000. Evaluation of a New Aerodynamic Particle Sizer® Spectrometer for MDI Size Distribution Measurements. Respiratory Drug Delivery VII. Raleigh, NC, Serentec Press.
17. Fuchs, N.A. 1963. Aerosol particles in a bipolar ionic atmosphere. Geofis. Pura Appl. 56:185.
18. Wiedensohler, A. 1988. Technical note: an approximation of the bipolar charge distribution for particles in the submicron size range. J. Aerosol Sci. 19:387-389.
19. Fink, J.B. 2000. Metered-dose inhalers, dry powder inhalers, and transitions. Respir. Care 45:623-635.
20. Feddah, M.R., Brown, K.F., Gipps, E.M., et al. 2000. In vitro characterisation of metered dose inhaler versus dry powder inhaler glucocorticoid products: influence of inspiratory flow rates. J. Pharm. Pharm. Sci. 3:318-324.
21. Leach, C.L. 1998. Relevance of radiolabeled steroid inhalation studies to clinical outcomes. J. Aerosol Med. Depos. Clear. Eff. Lung 11:S29-S34.
22. Shaik, M.S., Haynes, A., McSween, J., et al. 2002. Inhalation delivery of anticancer agents via HFA-based metered dose inhaler using methotrexate as a model drug. J. Aerosol Med. 15:261-270.
23. Fowler, S.J., Orr, L.C., Wilson, A.M., et al. 2001. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate. Br. J. Clin. Pharmacol. 52:93-95.
24. International Commission on Radiological Protection. 1994. Human respiratory tract model for radiological protection. Ann. ICRP 66.
25. Asgharian, B., Hofmann, W., and Miller, F.J. 2001. Mucociliary clearance of insoluble particles from the tracheobronchial airways of the human lung. J. Aerosol Sci. 32:817-832.